Retraction
Assessment of ocular surface disease in glaucoma patients with benzalkonium chloride-preserved latanoprost eye drops: a short-term longitudinal study
Paper Information
Record ID:
37051
Author(s):
Publication Date:
January 12, 2021
Retraction Date:
May 05, 2022
(3.5 years years ago)
Subjects:
Broad Categories:
Medicine
Medicine
Institutions:
- Department of Ophthalmology, National Taiwan University Hospital College of Medicine, National Taiwan University, No. 7, Chung-Shan S. Rd, Taipei, Taiwan
- Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan
- National Taiwan University College of Medicine, Taipei, Taiwan
- Department of Ophthalmology, National Taiwan University Hospital Hsin-Chu Branch, Hsin-Chu, Taiwan
Country:
🇹🇼 TaiwanArticle Type:
Publisher:
Springer
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (10)
10
Total Citations5
Post-Retraction(50.0%)
5
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
3
Within 1 year
0
After 2+ years
606
Days since retraction (latest)
Adverse events of topical ocular prostaglandin medications for glaucoma treatment: a pharmacovigilance study based on the FAERS database
Shi‐Nan Wu, Caihong Huang, Yuqian Wang et al. (12 authors)
Therapeutic Advances in Drug Safety
Open Access
Published: Jan 2024
5 citations
5 citations
606 days after retraction
Glaucoma and Dry Eye Disease: Opportunity to Assess and Treat
Lisa M. Nijm, Justin Schweitzer, Jennifer Gould Blackmore
Clinical ophthalmology
Open Access
Published: Oct 2023
7 citations
7 citations
514 days after retraction
Prevalence of Ocular Surface Disease and Associated Risk Factors in Glaucoma Patients: A Survey Study of Ophthalmologists
Nilgün Yıldırım, Banu Bozkurt, Nurşen Yüksel et al. (10 authors)
Turkish Journal of Ophthalmology
Open Access
Published: Oct 2022
9 citations
9 citations
176 days after retraction
A multicenter prospective comparative study evaluating cataract surgery and endoscopic cyclophotocoagulation either with or without iStent inject implantation in Brazilian patients with glaucoma
Francisco E. Lima, João C. Geraissate, Marcos P. Ávila
International Ophthalmology
Open Access
Published: Oct 2022
5 citations
5 citations
171 days after retraction
Topical glaucoma medications – Clinical implications for the ocular surface
Fredrik Fineide, Neil Lagali, Muhammed Yasin Adil et al. (7 authors)
The Ocular Surface
Open Access
Published: Jul 2022
31 citations
31 citations
87 days after retraction
Ocular Surface Disease in Glaucoma Patients
Christina Scelfo, Reem H. ElSheikh, Muhammad M. Shamim et al. (6 authors)
Current Eye Research
Published: Feb 2022
13 citations
13 citations
76 days before retraction
Advances of the Side Effects of Prostaglandin Eye Drops
叶 陆
Hans Journal of Ophthalmology
Published: Jan 2022
124 days before retraction
Ocular Surface Disease in Glaucoma Patients Randomized to Benzalkonium Chloride-Containing Latanoprost and Preservative-Free Bimatoprost
Jo‐Hsuan Wu, Tsing-Hong Wang, Jehn‐Yu Huang et al. (4 authors)
Journal of Ocular Pharmacology and Therapeutics
Published: Oct 2021
9 citations
9 citations
212 days before retraction
Efficacy and safety of newly developed preservative-free latanoprost 0.005% eye drops versus preserved latanoprost 0.005% in open angle glaucoma and ocular hypertension: 12-week results of a randomized, multicenter, controlled phase III trial
Joon Mo Kim, Ji Woong Lee, Haksu Kyung et al. (5 authors)
International Journal of Ophthalmology
Open Access
Published: Sep 2021
5 citations
5 citations
223 days before retraction
Efficacy and Tolerability of a New Latanoprost 0.005% BAK-Free Nanoemulsion: A Nonrandomized Open-Label Trial
Javier Fernando Casiraghi, Daniel E Grigera, J. Alejo Peyret et al. (5 authors)
Re GEN Open
Open Access
Published: Jun 2021
2 citations
2 citations
338 days before retraction
Quick Stats
Total Citations:
10
Years Since Retraction:
3.5 years
Open Access:
Yes
Last Checked:
Jul 24, 2025